191 related articles for article (PubMed ID: 22749643)
21. A new protocol for predicting novel GSK-3β ATP competitive inhibitors.
Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J
J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of glycogen synthase kinase 3 (GSK-3) inhibitors: an fast and atom efficient access to 1-aryl-3-benzylureas.
Monte FL; Kramer T; Boländer A; Plotkin B; Eldar-Finkelman H; Fuertes A; Dominguez J; Schmidt B
Bioorg Med Chem Lett; 2011 Sep; 21(18):5610-5. PubMed ID: 21807510
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel GSK-3β inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening.
Khanfar MA; Hill RA; Kaddoumi A; El Sayed KA
J Med Chem; 2010 Dec; 53(24):8534-45. PubMed ID: 21082766
[TBL] [Abstract][Full Text] [Related]
24. Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3.
Atilla-Gokcumen GE; Williams DS; Bregman H; Pagano N; Meggers E
Chembiochem; 2006 Sep; 7(9):1443-50. PubMed ID: 16858717
[TBL] [Abstract][Full Text] [Related]
25. 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
Zhang HC; Ye H; Conway BR; Derian CK; Addo MF; Kuo GH; Hecker LR; Croll DR; Li J; Westover L; Xu JZ; Look R; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2004 Jun; 14(12):3245-50. PubMed ID: 15149684
[TBL] [Abstract][Full Text] [Related]
26. Discovery of potent and bioavailable GSK-3beta inhibitors.
Gong L; Hirschfeld D; Tan YC; Heather Hogg J; Peltz G; Avnur Z; Dunten P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1693-6. PubMed ID: 20138512
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia.
Neumann T; Benajiba L; Göring S; Stegmaier K; Schmidt B
J Med Chem; 2015 Nov; 58(22):8907-19. PubMed ID: 26496242
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 3-benzisoxazolyl-4-indolylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3β.
Ye Q; Li M; Zhou Y; Pang T; Xu L; Cao J; Han L; Li Y; Wang W; Gao J; Li J
Molecules; 2013 May; 18(5):5498-516. PubMed ID: 23669633
[TBL] [Abstract][Full Text] [Related]
29. Identification of 2-(4-pyridyl)thienopyridinones as GSK-3β inhibitors.
Gentile G; Bernasconi G; Pozzan A; Merlo G; Marzorati P; Bamborough P; Bax B; Bridges A; Brough C; Carter P; Cutler G; Neu M; Takada M
Bioorg Med Chem Lett; 2011 Aug; 21(16):4823-7. PubMed ID: 21764580
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.
Bidon-Chanal A; Fuertes A; Alonso D; Pérez DI; Martínez A; Luque FJ; Medina M
Eur J Med Chem; 2013 Feb; 60():479-89. PubMed ID: 23354070
[TBL] [Abstract][Full Text] [Related]
31. Platinum complex as a nanomolar protein kinase inhibitor.
Williams DS; Carroll PJ; Meggers E
Inorg Chem; 2007 Apr; 46(8):2944-6. PubMed ID: 17375909
[TBL] [Abstract][Full Text] [Related]
32. Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3.
Sciú ML; Sebastián-Pérez V; Martinez-Gonzalez L; Benitez R; Perez DI; Pérez C; Campillo NE; Martinez A; Moyano EL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):87-96. PubMed ID: 30362380
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Shin D; Lee SC; Heo YS; Lee WY; Cho YS; Kim YE; Hyun YL; Cho JM; Lee YS; Ro S
Bioorg Med Chem Lett; 2007 Oct; 17(20):5686-9. PubMed ID: 17764934
[TBL] [Abstract][Full Text] [Related]
35. Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease.
Noh MY; Chun K; Kang BY; Kim H; Park JS; Lee HC; Kim YH; Ku S; Kim SH
Biochem Biophys Res Commun; 2013 May; 435(2):274-81. PubMed ID: 23632329
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationship of 4-quinolone-3-carboxylic acid based inhibitors of glycogen synthase kinase-3β.
Cociorva OM; Li B; Nomanbhoy T; Li Q; Nakamura A; Nakamura K; Nomura M; Okada K; Seto S; Yumoto K; Liyanage M; Zhang MC; Aban A; Leen B; Szardenings AK; Rosenblum JS; Kozarich JW; Kohno Y; Shreder KR
Bioorg Med Chem Lett; 2011 Oct; 21(19):5948-51. PubMed ID: 21873061
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic.
Medina M; Castro A
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):533-43. PubMed ID: 18600569
[TBL] [Abstract][Full Text] [Related]
40. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation.
Mohammad M; Al-Masri IM; Issa A; Al-Ghussein MA; Fararjeh M; Alkhatib H; Taha MO; Bustanji Y
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):690-4. PubMed ID: 22512725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]